Study of Heart Structure to Predict Risk of Sudden Cardiac Death in Patients with Poor Heart Function Using ICDs
Led by Johns Hopkins University · Updated on 2026-01-20
400
Participants Needed
2
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
Sudden cardiac death SCD is a major health challenge with a high number of cases each year and low survival rates. Implantable cardioverter defibrillators ICDs help prevent SCD in patients with poor heart function, specifically those with left ventricular ejection fraction LVEF of 35% or less. However, current selection methods mean only a small portion of patients truly benefit from ICDs, creating a need for better ways to predict who is at risk. This research focuses on whether detailed structural features of the heart, beyond overall heart function, can better predict SCD risk using cardiac magnetic resonance imaging CMR.
The study uses CMR with late gadolinium enhancement to measure detailed heart structure, including function, size, mass, shape, and scar tissue in patients with reduced LVEF who are being considered for ICDs to prevent SCD. It aims to see if these structural measurements combined with other clinical factors can more accurately identify patients at higher risk of SCD compared to current methods. This prospective study involves a large group of patients to assess the added value of heart structure assessment in predicting SCD risk.
Participants will be followed for up to five years with evaluations every six months to monitor outcomes related to SCD and other cardiac events. Researchers will review composite outcomes of sudden cardiac death and cardiac health over this period. The study involves clinical assessments and imaging tests to collect data and track participants health status, aiming to improve future risk stratification for SCD prevention and better target ICD therapy.
CONDITIONS
Brief Title
Left Ventricular Structural Predictors of Sudden Cardiac Death
Research Team
K
Katherine Wu, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Left ventricular ejection fraction (LVEF) of 35% or less
Referred clinically for implantable cardioverter defibrillator (ICD) insertion for primary prevention (no prior sustained ventricular arrhythmias)
Between 21 and 80 years old
Permission from the patient's clinical attending physician
You will not qualify if you...
Refusal or inability to give consent
Contraindications to MRI such as implanted metallic objects (e.g., pacemakers, cerebral clips, metallic projectiles)
Under 21 years old (minors)
Pregnant women
New York Heart Association (NYHA) Class IV heart failure
Chronic renal insufficiency with creatinine clearance less than 60 ml/min or any acute renal insufficiency
Claustrophobia
Prior adverse reaction to gadolinium-based contrast
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Diagnostic Evaluation
Duration - Single assessment
Participants undergo detailed cardiac magnetic resonance imaging (CMR) to assess left ventricular structure and function.
1 visit (in-person)
Long-term Monitoring
Duration - Up to 5 years
Participants are monitored for sudden cardiac death and cardiac outcomes over time to evaluate risk based on LV structural indices.
Visits every 6 months for up to 5 years
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Phase 2 Study of 18F-mFBG PET Imaging
for Heart Failure Patients with Ischemic Cardiomyopathy
and Implantable Cardioverter-Defibrillators
Open-label Dose-escalation Study Evaluating Safety of HB1011 Stem Cell Therapy Injected During Coronary Artery Bypass Surgery in Ischemic Cardiomyopathy Patients
Study of Ablation-Index Guided Scar-Related Ventricular Tachycardia Treatment in Patients with Ischemic Cardiomyopathy
Randomized Trial Comparing AI-Guided vs Standard Ablation Procedures
Using Your Own Heart Tissue to Support Repair During Coronary Artery Bypass Surgery
AAMS2 Trial on Atrial Appendage Micrograft Transplants for Ischemic Heart Disease
Exploring 5Gy Whole Heart Radiotherapy Treatment for Advanced Refractory Heart Failure
Evaluating Its Effect on Heart Function and Patient Outcomes
Study Comparing Outcomes of Left Bundle Branch Pacing Versus Conventional Biventricular Pacing
in Patients With Chronic Heart Failure and Reduced Heart Pump Function
Comparing Endo-Epicardial Versus Endocardial-Only Catheter Ablation for Ventricular Tachycardia in Ischemic Cardiomyopathy Patients
Mapping Heart Fibroblast Activation Using FAPI PETCT Imaging in Nonischemic Cardiomyopathy
National Registry for Patients Receiving Implantable Cardioverter Defibrillators ICDs and Cardiac Resynchronization Therapy Devices with Defibrillators CRT-Ds
Study of Left Bundle Branch Pacing to Improve Heart Function and Outcomes in Patients Who Do Not Respond to Standard Biventricular Cardiac Resynchronization Therapy
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Enhanced infarct border zone function and altered mechanical activation predict inducibility of monomorphic ventricular tachycardia in patients with ischemic cardiomyopathy.
Verônica Rolim S Fernandes, Katherine C Wu, Boaz D Rosen...
Association of left ventricular tissue heterogeneity and intramyocardial fat on computed tomography with ventricular arrhythmias in ischemic cardiomyopathy.
ECG quantification of myocardial scar in cardiomyopathy patients with or without conduction defects: correlation with cardiac magnetic resonance and arrhythmogenesis.
David G Strauss, Ronald H Selvester, João A C Lima...